Head-to-head · WeighScore
Goldspan Health vs MadeMed
The verdict
MadeMed takes it — 80.4/100 to 68.2/100.
MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Goldspan Health | MadeMed |
|---|---|---|
| WeighScore | 68.2/100 | 80.4/100 |
| Grade | C | B− |
| Site position | #169 | #23 |
| Semaglutide | $229 per 28 days (a single plan; thirteen charges a year) | $239/mo quarterly (from $199/mo on 6 months) |
| Tirzepatide | $299 per 28 days (a single plan; thirteen charges a year) | $399/mo quarterly (from $369/mo on 6 months) |
| Coverage | All 50 states plus Washington, D.C. | 40 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #169 · C
Strengths
- One plan per molecule with no tier ladder to read, which removes the commonest source of a misquoted price
- Sublingual full-dose and microdose lines sit alongside the injections for readers who will not inject
- States its compounding class — dispensed by a pharmacy licensed under 503A or 503B — rather than leaving it unsaid
- Names a medical director and two clinical advisors by name and specialty
- A lab panel is genuinely required at 60 to 90 days and annually after that, which is stronger monitoring than most of this ranking asks for
Where it loses points
- The required lab panel is described as available at a low cost and its cost is stated nowhere on the site
- The hero says “/month”, the plan card says billed every 28 days and the order timeline says every four weeks — thirteen charges a year, not twelve
- “Pause, delay, or cancel at any time” on the storefront sits against a refund policy reading “all sales are final” and platform terms saying an order cannot be canceled once placed
- The tirzepatide sublingual microdose page lists compounded sublingual semaglutide microdose in its own inclusion list
- Clinicians are attributed to a partner platform while the storefront states it is not a medical practice
- No pharmacy is named, and Goldspan publishes no legal entity, address or governing law of its own
- Full-dose sublingual products exist on the catalog and are not linked from the site's own weight-loss page
Site position #23 · B−
Strengths
- One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
- LegitScript verified, with board-certified physician review and US compounding pharmacies
- Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
- Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies
Where it loses points
- The most expensive tirzepatide here at $399/mo quarterly
- 40 states rather than nationwide
- No published recurring lab program
- Ships one vial every two months, a less flexible cadence than a monthly refill
Featured provider
MadeMed
MadeMed scores 80.4/100 (B−). Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.